From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

OptiBiotix Health – “Commercial update”, a trading progress improving BUY, shares to almost double from here

By Hotstockrockets | Saturday 24 August 2024


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


OptiBiotix Health (OPTI) has issued a “Commercial update” announcement including that at end-July the 2024 calendar year sales orders surpassed its 2023 full-year revenue and, with all of its products targeting growing market trends in lifestyle-related health challenges and large partners longer timescales starting to reach initial orders, it “look to the future with a high degree of confidence”. This was also the tone of a chat we enjoyed with CEO Stephen O’Hara today.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

Tom

Photo Article from Sharestock: tea

Wednesday »

Bearcast

Tom Winnifrith Bearcast: red flags and bubbles

 

SDI

SDI Group – again a Buy?

 

Tom

Feeling Thirsty Evil Banksta?

Time left: 15:19:25